Improved quantification of HIV-1 infected CD4 + T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection by Yang, Hongbing et al.
	 	
	
 
 
 
This	is	the	authors’	final	peered	reviewed	(post	print)	
version	of	the	item	published	as:	
 
	
Yang,	Hongbing,	Yorke,	Elizabeth,	Hancock,	Gemma,	Clutton,	Genevieve,	Sande,	Nellia,	Angus,	
Bryan,	Smyth,	Redmond,	Mak,	Johnson	and	Dorrell,	Lucy	2013,	Improved	quantification	of	HIV‐1	
infected	CD4	+	T	cells	using	an	optimised	method	of	intracellular	HIV‐1	gag	p24	antigen	detection,	
Journal	of	Immunological	Methods,	vol.	391,	no.	1‐2,	pp.	174‐178.	
	
	
	
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30059493	
	
	
	
	
Reproduced	with	the	kind	permission	of	the	copyright	owner.		
	
Copyright	:	2013,	Elsevier	
Improved quantification of HIV-1-infected CD4+ T cells using an optimised 
method of intracellular HIV-1 gag p24 antigen detection 
Hongbing Yanga, Elisabeth Yorkeb, Gemma Hancocka, Genevieve Cluttonb, Nellia 
Sandec, Brian Angusb, Redmond Smythd, Johnson Make, Lucy Dorrella,b,c 
 
a Oxford NIHR Biomedical Research Centre and b Nuffield Department of Medicine, 
University of Oxford, Oxford OX3 9DS, UK 
c Oxford Genitourinary Medicine, Oxford University Hospitals NHS Trust, Oxford 
OX3 7LJ, UK 
d Architecture et Réactivité de l'ARN, Institut de Biologie Moléculaire et Cellulaire, 
Université de Strasbourg, Centre National de la Recherche Scientifique, Strasbourg, 
France  
e School of Medicine, Deakin University, Victoria, Australia 3216 
 
Address for correspondence: Dr Lucy Dorrell, Weatherall Institute of Molecular 
Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK. Tel: +44 1865 222145 
 
Abstract
The capacity of CD8+ T cells to inhibit HIV-1 replication in vitro strongly correlates 
with virus control in vivo. Post-hoc evaluations of HIV-1 vaccine candidates suggest 
that this immunological parameter is a promising benchmark of vaccine efficacy. 
Large-scale analysis of CD8+ T cell antiviral activity requires a rapid, robust and 
economical assay for accurate quantification of HIV-1 infection in primary CD4+ T 
cells. Detection of intracellular HIV-1 p24 antigen (p24 Ag) by flow cytometry is one 
such method but it is thought to be less sensitive and quantitative than p24 Ag ELISA. 
We report that fixation and permeabilisation of HIV-infected cells using 
paraformaldehyde / 50% methanol / Nonidet P-40 instead of a conventional 
paraformaldehyde / saponin-based protocol improved their detection across 
multiplicities of infection (MOI) ranging from 10-2-8x10-5, and by nearly two-fold (p 
<0.001) at the optimal MOI tested (10-2). The frequency of infected cells was strongly 
correlated with p24 Ag release during culture, thus validating its use as a measure of 
productive infection. We were also able to quantify infection with a panel of HIV-1 
isolates representing the major clades. The protocol described here is rapid and cost-
effective compared with ELISA and thus could be a useful component of immune 
monitoring of HIV-1 vaccines and interventions to reduce viral reservoirs. 
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1. Introduction 
Better understanding of the defining characteristics of effective immunity to HIV-1 is 
crucial to the development of effective vaccines and eradication strategies. CD8+ T 
cell-mediated viral inhibition in vitro provides a direct measure of immune control of 
HIV-1 in vivo and has therefore been evaluated as a possible benchmark of effective 
immunity in vaccine trial cohorts (Freel et al., 2010; Saez-Cirion et al., 2007; 
Spentzou et al., 2010; Yang et al., 2012). Analysis of CD8+ T cell antiviral activity 
requires accurate quantification of HIV-1 infection in primary CD4+ T cells. A 
widely used approach involves quantification by ELISA of viral gag p24 Ag released 
by infected cells during culture, with or without autologous CD8+ T cells, for up to 21 
days (Fauce et al., 2007; Saez-Cirion et al., 2010; Spentzou et al., 2010). 
Alternatively, the frequency of infected cells can be assessed by flow cytometric 
analysis of intracellular p24 Ag. The reproducibility, sensitivity and dynamic range 
that can be achieved using p24 Ag ELISA supported the perception that it is superior 
to flow cytometry for analysis of patient cohorts (Saez-Cirion et al., 2010). However, 
the disadvantages of the ELISA-based approach (time and cost) led us to optimise the 
intracellular assay in order to facilitate rapid analysis of CD8+ T cell antiviral activity 
(Yang et al., 2012). Here, we show that the sensitivity of the intracellular p24 Ag 
assay is highly dependent on the method of fixation and permeabilisation.  
 
2. Materials and Methods 
2.1 Subjects 
Ethical approval was given by Mid & South Buckinghamshire Research Ethics 
Committee, UK (Ethics ref. 08/H0607/51). Each participant provided written 
informed consent. Chronic HIV-1 infected antiretroviral therapy-naive adults were 
recruited from clinics in Oxford, UK. Peripheral blood mononuclear cells (PBMC) 
from healthy HIV-uninfected donors were obtained from buffy coats supplied by the 
National Health Service Blood Transfusion Service, Bristol, UK or from the 
Weatherall Institute of Molecular Medicine (University of Oxford) Licensed Tissue 
Bank, in compliance with the Human Tissue Act 2004. PBMC were stored in vapour 
phase liquid nitrogen until use. 
 
2.2 Viruses 
HIV-1 isolates were obtained from the Programme EVA Centre for AIDS Reagents, 
National Institute for Biological Standards and Control (NIBSC), a centre of the 
Health Protection Agency, UK. The laboratory-adapted CCR5-tropic clade B isolate 
BaL was used as a reference strain throughout all experiments. Other laboratory-
adapted and primary isolates of various clades were used in selected experiments. 
These were HIV-1 IIIB (clade B, CXCR4-tropic), HIV-1 92UG029 (clade A, CCR5 / 
CXCR4 dual-tropic), HIV-1 RW93024 (clade A, CXCR-tropic), HIV-1 ES X-1936 
(clade C, CCR5-tropic) and HIV-1 CRF_14 (BG recombinant, CCR5 / CXCR4 dual-
tropic) (Supplementary Table 1). All virus propagation was performed using primary 
CD4+ cells and 50% tissue culture infectious doses (TCID50) for each virus was 
calculated as described previously (Koup et al., 2001). In selected experiments, 
NLAD8 EGFP IRES_Nef, which is an R5-tropic HIV-1 isolate that expresses EGFP 
from the Nef open reading frame, was used to confirm productive infection. Viral 
stocks were prepared by transfection of 293T cells with polyethylenimine. After 36 
hours, virus-containing supernatant was harvested, filtered and frozen at -80oC. 
2.3 Quantification of HIV-1-infected CD4+ T cells by intracellular p24 
antigen staining 
Cryopreserved PBMC were thawed and depleted of CD8+ cells by magnetic bead 
separation (MACS, Milteny-Biotec). CD8-depleted cells (hereafter referred to as 
CD4+ cells) were stimulated with PHA (5μg/ml) in RPMI-1640 medium 
supplemented with 10% FCS (‘R10’) for 3 days, washed and infected with HIV-1 
isolates at multiplicities of infection (MOI) ranging from 10-2-10-3 as indicated in 
Supplementary Table 1. The selected MOI were those that yielded detectable 
infection in all wells when tested a TCID50 assay without causing significant cell 
death (>20% lymphocytes Aqua Live/Dead-positive). In some experiments, HIV-1BaL 
was tested over a wider range of MOI (Table 1). Infection was achieved by 
spinoculation for 2 hours at 25oC, after which cells were washed twice and cultured in 
triplicate (5 x 104 cells / well) in R10 supplemented with IL-2 (20 IU/ml) for 5-11 
days. Supernatants were collected and stored at -80oC for p24 Ag ELISA. Cells were 
then harvested and stained first with Aqua Live/Dead Fixable stain (Invitrogen), fixed 
with 4% paraformaldehyde (PFA) / lysolecithin (20μg/ml) at RT, then resuspended in 
cold 50% methanol for 15 minutes. Further permeabilisation was achieved with 0.1% 
Nonidet P-40 and cells were then stained with antibodies to p24 Ag (KC-57-FITC, 
Beckman Coulter) followed by antibodies to CD3, CD4 and CD8 (conjugated to 
APC-Cy7, PerCP and APC respectively; BD Biosciences). In selected experiments, 
cells were permeabilised and stained as described elsewhere using proprietary fixation 
and permeabilisation reagents (BD Biosciences) (Saez-Cirion et al., 2010). Samples 
were acquired on a CyAn flow cytometer and analysed using FlowJo (version 9.2). 
Compensation values never exceeded 40%. The frequency of infected CD4+ T cells 
was defined as the percentage of HIV-1 p24 Ag+ cells among live single CD3+ CD8-
negative lymphocytes. Supernatant p24 Ag concentration was determined by ELISA 
(Cell Biolabs Inc.) according to the manufacturer’s protocol. 
 
2.4 Statistical analysis 
Statistical analysis was performed using GraphPad Prism software (version 4). Paired 
samples were analysed using a paired t test. Associations were examined by 
calculation of Pearson’s correlation coefficient. All tests were two-tailed and P values 
<0.05 were considered significant. 
 
3. Results 
3.1 Optimisation of intracellular staining for HIV-1 p24 Ag to identify 
infected primary CD4+ T cells 
Optimal detection of p24 Ag in HIV-infected human cell lines and PBMC requires 
cell fixation with cold methanol at 90% v/v concentration; however, this is 
unsatisfactory for multi-parameter FACS analysis of primary human T cells as 
methanol concentrations >50% can interfere with the detection of CD3 on the cell 
surface (Chow et al., 2005; Cory et al., 1987). We therefore investigated the effect of 
treatment of HIV-1BaL- infected primary CD4+ T cells with different methanol 
concentrations prior to antibody staining. The highest frequency of p24 Ag+ cells was 
observed after treatment with 75% methanol. However, this was associated with >0.5 
log10 reduction in CD3 expression, whereas 50% methanol did not substantially 
impair detection of either p24 Ag or CD3 (Fig. 1A, B). Conversely, 35% methanol 
had minimal effect on CD3 but reduced detection of p24 Ag+ cells by 24%. We then 
compared the treatment of HIV-1BaL infected CD4+ T cells from 9 healthy donors 
with either 4% PFA / 50% methanol followed by Nonidet p40 (‘50% methanol perm’) 
or proprietary PFA / saponin (‘BD perm’) as described previously, before addition of 
antibodies (Saez-Cirion et al., 2010). With both methods, non-specific staining with 
the p24 antibody was low, although higher with the BD perm method than with 50% 
methanol (0.21% vs. 0.17%). Significantly higher frequencies of infected CD4+ T 
cells (defined as p24+ cells to allow for nef-induced CD4 downregulation) were 
detected using 50% methanol perm (median 12.0%, range 4.6%-22.6%) than the BD 
perm method (median 7.2%; range 1.1%-16.3%, p = 0.001) (Fig. 1C).  
 
It is possible that infected CD4+ T cells can express p24 Ag in the absence of 
productive infection since abundant protein is present on incoming virus (Marechal et 
al., 1998). To address this, we compared the frequencies of infected cells from 13 
subjects with the concentration of p24 Ag released during a 5 day culture period. 
These parameters were highly correlated (r = 0.85, p = 0.0002) ( (Fig. 1D). In 
addition, to confirm productive infection by a direct method we used an EGFP-
expressing R5-tropic HIV-1 isolate to infect CD4+ cells. GFP-positive cells were 
detected after a minimum of 18 hours of infection, consistent with expected viral 
replication kinetics, and were >97.5% positive by p24 Ag staining (Figure 1E). These 
data indicate that our intracellular staining protocol provides a robust measure of 
productive infection.  
 
3.2 Relative sensitivities of optimised flow cytometric intracellular p24 assay 
and p24 ELISA 
A reported limitation of the flow cytometric assay is its poor sensitivity relative to 
ELISA. To investigate the lower limit of detection of p24 Ag+ cells in the BD perm-
and methanol-based flow cytometric assays, we tested HIV-1BaL at MOIs ranging 
from 1x10-2-4x10-6. Corresponding supernatants were tested by ELISA. The BD-perm 
based assay yielded consistently lower p24 Ag+ cell frequencies than the methanol-
based assay at MOIs of 1x10-2-8x10-5, therefore, only the latter was compared with 
ELISA in an end-point assay (Table 1).  Wells were scored positive in the methanol-
based flow cytometric assay if the frequency of p24 Ag+ cells was >0.45%. (based on 
the mean + 3 SD of mock-infected CD4+ cells from 8 donors tested in triplicate). The 
cut-off for the p24 ELISA stated in the manufacturer’s protocol was 1562 pg/ml. The 
methanol-based flow cytometric assay and ELISA scored positive in all wells at all 
MOIs tested except the lowest (4x10-6). At this MOI, 1/3 wells were scored positive in 
the optimised flow cytometric assay; 3/3 wells were positive by ELISA (Table 1). 
3.3 Intracellular p24 Ag staining reliably detects infection of primary CD4+ 
T cells with diverse HIV-1 isolates 
The HIV-1 clade B isolate, BaL was chosen for optimisation of the intracellular p24 
Ag assay because, as an R5-tropic virus, it is representative of the majority of 
transmitted strains. To extend our initial findings we tested a panel of primary and 
laboratory-adapted viruses that represent the major clades and vary in their tropism, 
replicative capacity and cytopathicity in primary CD4+ cell cultures. The clade B 
laboratory-adapted isolates BaL and IIIB and the primary clade C isolate showed a 
plateau in viral replication 5-7 days after infection, while the primary clade A isolates 
plateaued as early as day 3. The BG recombinant virus infected a very high proportion 
of CD4+ T cells, resulting in rapid cell death (>50%), which made interpretation of 
the data unreliable (Fig. 2). At the peak of virus replication, frequencies of infected 
cells varied considerably across the panel, with median values ranging from 8.5% p24 
Ag+ cells for HIV-1BaL to 25.6% for the BG recombinant. In summary, our assay 
enabled quantification of infection with diverse virus isolates. 
4. Discussion 
We have shown that the sensitivity of a flow cytometric assay to detect intracellular 
p24 Ag is significantly enhanced by use of a methanol-based staining protocol. While 
less sensitive than a commercially available ELISA in a limiting dilution assay using 
a stringent cut-off, the methanol-based flow cytometric assay could detect infection at 
MOIs as low as 4x10-6. Optimal infected cell frequencies were previously defined  as 
10-30% p24 Ag+ CD4+ T cells by intracellular staining on day 3 of infection, as this 
was considered necessary to achieve a p24 Ag concentration in the culture supernatant 
of 100-1000 ng/ml at the peak of viral replication (usually day 5-7 in the case of HIV-
1BaL) (Saez-Cirion et al., 2010). Here, we observed that p24 Ag concentrations 
exceeded 100 ng/ml after 5 days’ infection with HIV-1BaL in >90% cases, despite 
wide inter-individual variation in frequencies of infected CD4+ T cells (5-23%), 
highlighting the efficiency of infection with HIV-1BaL. While the flow cytometric 
assay has a smaller dynamic range than ELISA, which may limit its capacity to 
identify individuals with very potent CD8+ T cell function in viral inhibition assays, it 
nevertheless allows for real-time assessment of spresd of infection and cell viability. 
This is essential to correct interpretation of data, particularly when comparing 
different viral isolates that may vary in cytopathicity.  
 
ELISA is generally ideal for large-scale analyses, however, a major disadvantage is 
that the recommended kinetic approach requires several dilutions of culture 
supernatant per sample analysed; this requires judgement by the user and may vary 
between assays. This limits the number of individual patients’ samples that can be 
analysed in a single plate, with potentially substantial cost implications. The flow 
cytometric assay was calculated to be 25% of the cost of ELISA, based on the 
analysis of duplicate ELISA samples at two dilutions for a single culture time-point 
(Supplementary Table 2). In addition, the flow cytometric assay is less time-
consuming (5 vs. 10 hours from cell / supernatant harvest to completion of acquisition 
of data by a single operator, as the ELISA protocol includes incubations of 4 hours or 
overnight with the p24 antibody). Automated sampling of 96 well plates could shorten 
the duration of the flow cytometric assay further still. When testing multiple virus 
isolates, it is also easy to adapt the flow cytometry assay according to the replication 
characteristics of the viral strains being studied. Although installation and 
maintenance of a flow cytometer is costly, this technology is employed widely in 
resource-limited settings for the purpose of analysing T cell responses in HIV-1 
vaccine trials.  
 
In summary, the advantages of the flow cytometric assay described here support its 
inclusion as a component of immune monitoring in clinical trials of HIV-1 vaccine 
candidates. Finally, recent intriguing data suggest that latently HIV-infected CD4+ T 
cells can produce gag proteins without spreading infection (Pace et al., 2012). 
Accurate quantification of HIV-1 gag-expressing CD4+ T cells could complement 
other methods to evaluate eradication strategies targeting virus reservoirs. 
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Figure legends 
Figure 1.
Quantification of in HIV-1 infection in primary CD4+ T cells by optimised 
intracellular staining 
A. Effect of methanol concentration on detection of intracellular p24 Ag in HIV-1BaL-
infected CD4+ T cells (gated on CD3+ CD8neg live lymphocytes in all figures to allow 
for nef-induced CD4 downregulation) after 5 day culture; values for individual culture 
wells are shown in right-hand panel. (B) Effect of methanol concentration on cell 
surface CD3 expression. Data are representative of two independent experiments and 
a minimum of 20,000 gated events were acquired. 
C. Comparison of ‘50% methanol perm’ with a standard protocol (‘BD perm’) for 
detection of HIV-infected CD4+ T cells from 9 healthy donors. Symbols indicate 
corresponding data from each donor.  
D. Frequencies of HIV-1BaL-infected CD4+ T cells were determined in 13 subjects on 
day 5 after infection using the methanol-based protocol; cumulative p24 Ag in 
supernatants during 5 days’ culture was quantified by ELISA. Data represent means 
of duplicate or triplicate wells.  
E. Primary CD4+ cells were infected with NLAD8 EGFP IRES_Nef and cultured for 
5 days, then stained for p24 Ag using the methanol-based protocol.  
 
Figure 2
Infection rate of primary and laboratory-adapted HIV-1 isolates in primary 
CD4+ T cells 
CD4+ T cells from 16 subjects were infected with various HIV-1 isolates at MOIs 
indicated in Supplementary Table 1 and cultured for 11 days prior to FACS analysis.  
A. Representative data from one subject showing infection rate according to virus 
isolate and duration of culture.  
B. Median peak infection rate for each virus is indicated by horizontal line (IQR - 
error bars). number of subjects  tested  with each viral isolate was follows: BaL -10, 
IIIB – 9, A1 – 10, A2 -10, C- 10, BG – 10 (3 subjects were tested with all 6 viruses). 
The donor used in panel A is indicated by symbol X.  
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Supplementary Table 1 HIV-1 isolates  
Isolate Clade Primary isolate Tropism MOI 
BaL B No R5 10-2
IIIB B No X4  2x10-3
92UG029 A (A1*) Yes R5/X4 10-3
RW93024  A (A2*) Yes X4  3x10-3
ES X-1936 C Yes R5  9x10-3
CRF_14 BG* Yes R5/X4 10-2
* Isolate identifier used in Fig. 2 
Supplementary Table 2 
Costs of viral inhibition assay using optimised intracellular p24 assay and p24 ELISA 
(USD, based on one E:T ratio, one time-point) 
Assay Flow cytometry a ELISAb
Number of culture wells (duplicate wells of 
uninfected CD4, HIV-infected CD4 alone, HIV-
infected CD4 + CD8) 
6 6 
Number of samples generated for analysis per 
subject
6 24 
Cost per sample analysed 6.36 6.65 
Cost per subject analysed 38.11 160.00 
a Antibody costs per sample analysed: KC57-FITC (p24 Ag, Beckman Coulter) – $1.89; CD3-
APC-Cy7 (Biolegend) - $0.53; CD8-APC (Biolegend) - $0.30; CD4-perCP (BD) - $1.38; 
Aqua Live/Dead (Invitrogen) - $1.22; Compensation beads (BD) - $1.03 
b QuickTitre HIV Lentivirus Quantitation Kit, Cell Biolabs Inc. (San Diego, USA): cost of 5 
kits - $3291. Costs 15% higher for a single kit. Each 96 well plate has 80 wells available for 
sample analysis. 
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